AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

📰

Parkinson's disease symptom measurement: the latest breakthroughs

Everything that changed in the last year, from three public sources: phase 3 trials that posted their results, papers in the leading medical and cancer journals, and US drug labels that were updated. Refreshed every week.

🤖

What changed

Written by AI from the evidence below, every point cited

AI reads the results, papers and label updates below and explains what changed and why it matters, citing each source. It is shared with everyone.

🏁

Phase 3 results posted

The large trials that decide new standard treatments · ClinicalTrials.gov

No phase 3 results were posted in the last year.

📚

In the leading journals

NEJM, Lancet, Nature, JCO, Cancer Cell and more · PubMed
Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial.Nat Med 2026 · PMID 42926233 Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial.Nat Med 2026 · PMID 42919966 The human microbiome and chronic disease: ten strategic priorities for research and public health.Nat Med 2026 · PMID 42919965 Rilvegostomig Plus Trastuzumab-Deruxtecan for Early-Stage Breast Cancer: The I-SPY2.2 Randomized Clinical Trial.JAMA Oncol 2026 · PMID 42911610 Global and regional burden of measles and vaccine coverage among children under 5 years, 1990-2023: a Global Burden of Disease Study.Nat Med 2026 · PMID 42907529 Global, regional and national burden of pertussis in 1990-2023: a Global Burden of Disease study.Nat Med 2026 · PMID 42907527 The anatomy of a personal health agent.Nature 2026 · PMID 42907512 Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations.Cancer Cell 2026 · PMID 42887497 Nearly half of reef-building corals face elevated relative risk of extinction.Nature 2026 · PMID 42880730 Comprehensive benchmarking of somatic mutation detection by the SMaHT Network.Cell 2026 · PMID 42880231 Personalized neoantigen-targeting cancer vaccines in ovarian cancer: a phase 1 trial.Nat Med 2026 · PMID 42875558 Engineered TYK2 dependence enables myeloid-selective IL-10 receptor agonism.Nature 2026 · PMID 42875499
🏛️

US drug labels updated

A label changes when a new use, dose or warning is approved · openFDA

No label updates found.

An update is not always a new approval — open the label to see what changed.

Want these every week? Follow Parkinson's disease symptom measurement and get a note on your phone with the new trials and papers.

🔔 Follow Parkinson's disease symptom measurement
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy